Pain related to cancer treatments and diagnostic procedures: a no man's land?
Open Access
- 13 March 2014
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 25 (6) , 1097-1106
Abstract
While guidelines are available for the management of cancer-related pain, little attention is given to the assessment and treatment of pain caused by treatments and diagnostic procedures in cancer patients. We evaluated the literature on pain related to cancer treatment and diagnostic procedures within a critical analysis. The data available are sparse, suggesting that little attention has been directed at this important aspect of oncology. This points to potentially suboptimal patient management. Appropriate studies are necessary in order to understand the incidence and appropriate management of pain, both during and/or after oncological treatments and diagnostic procedures. At the same time, Health Care Professionals should have heightened awareness of the causes and treatment of pain with the aim of anticipating and managing pain most appropriately for each individual patient. This is clearly an important component of holistic patient care before, during, and after oncological treatment.Keywords
This publication has 118 references indexed in Scilit:
- Strategies of pain reduction during the bone marrow biopsyAnnals of Hematology, 2012
- Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPCThe Lancet Oncology, 2012
- Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicitiesSupportive Care in Cancer, 2011
- Pattern and quality of care of cancer pain management. Results from the Cancer Pain Outcome Research Study GroupBritish Journal of Cancer, 2009
- Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudesAnnals of Oncology, 2009
- Prevalence of undertreatment in cancer pain. A review of published literatureAnnals of Oncology, 2008
- Barriers to pain assessment and management in cancer survivorshipJournal of Cancer Survivorship, 2008
- Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trialThe Lancet Oncology, 2008
- Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitorsBreast Cancer Research and Treatment, 2007
- Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trialThe Lancet, 2007